Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single-centre, Retrospective, Cohort study to evaluate the conversion from Calcineurin Inhibitor to Belatacept in kidney transplant recipients.

Trial Profile

A Single-centre, Retrospective, Cohort study to evaluate the conversion from Calcineurin Inhibitor to Belatacept in kidney transplant recipients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jul 2018

At a glance

  • Drugs Belatacept (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jul 2018 New trial record
    • 06 Jun 2018 Results assessing 12-month evolution of Anti-HLA Antibodies Donor Specific Antibodies after rescue conversion from Calcineurin Inhibitor to Belatacept (n=47) presented at the 2018 American Transplant Congress
    • 06 Jun 2018 Results assessing the effect and reasons of rescue switch from Calcineurin Inhibitor to Belatacept (n=73) presented at the 2018 American Transplant Congress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top